Global T2T survey

The global T2T survey is a quantitative global survey to assess perceived regional and local barriers to, and facilitators of, real-world T2T implementation among rheumatologists. 

The objectives of the global survey:  

• Complement insights and validate the findings of the CQP report with recent real-world data
• Identify global, regional, and local gaps and drivers of T2T implementation to help with the prioritization of interventions to close these gaps locally
• Inform future global and local tactics in EVEREST Phase 3
• Potential to serve as a quantitative baseline assessment for evaluating the impact of the T2T implementation toolkits.

Our global T2T survey was developed by http://www.axdevgroup.com AXDEV Group Inc, an international performance improvement research organization, to assess perceived regional and local barriers to, and facilitators of, real-world T2T implementation. This survey is being conducted in >35 countries globally with the support of a global executive steering committee (ESC) of experts in RA.

Data will be collected in collaboration with AbbVie but will be stored and analyzed by AXDEV independently of AbbVie. All individual data will be kept strictly confidential and anonymous. Only aggregated data and findings will be shared with AbbVie.